Abacavir
The serum concentration of Abacavir can be decreased when it is combined with Imidapril.
Acebutolol
Acebutolol may increase the hypotensive activities of Imidapril.
Aceclofenac
The risk or severity of adverse effects can be increased when Aceclofenac is combined with Imidapril.
Advertisement
Acemetacin
The therapeutic efficacy of Imidapril can be decreased when used in combination with Acemetacin.
Acetyl salicylate
The therapeutic efficacy of Imidapril can be decreased when used in combination with Acetylsalicylic acid.
Adapalene
The risk or severity of adverse effects can be increased when Adapalene is combined with Imidapril.
Advertisement
Aldesleukin
The risk or severity of adverse effects can be increased when Imidapril is combined with Aldesleukin.
Alfuzosin
The serum concentration of Alfuzosin can be increased when it is combined with Imidapril.
Aliskiren
Aliskiren may increase the hypotensive, nephrotoxic, and hyperkalemic activities of Imidapril.
Advertisement
Allopurinol
The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Imidapril.
Alminoprofen
The risk or severity of adverse effects can be increased when Alminoprofen is combined with Imidapril.
Alogliptin
The risk or severity of adverse effects can be increased when Alogliptin is combined with Imidapril.
Aloxiprin
The therapeutic efficacy of Imidapril can be decreased when used in combination with Aloxiprin.
Alprazolam
The serum concentration of Alprazolam can be increased when it is combined with Imidapril.
Alprenolol
Alprenolol may increase the hypotensive activities of Imidapril.
Ambrisentan
Imidapril may increase the hypotensive activities of Ambrisentan.
AMBROXOL ACEFYLLINATE
The serum concentration of Ambroxol acefyllinate can be decreased when it is combined with Imidapril.
Ambroxol-Theophylline-7-Acetate
The serum concentration of Ambroxol acefyllinate can be decreased when it is combined with Imidapril.
Amifostine
Imidapril may increase the hypotensive activities of Amifostine.
Amifostine Anhydrous
Imidapril may increase the hypotensive activities of Amifostine.
Amiloride
Amiloride may increase the hyperkalemic activities of Imidapril.
Amineptin
The serum concentration of Amineptine can be increased when it is combined with Imidapril.
Aminophylline
The serum concentration of Aminophylline can be decreased when it is combined with Imidapril.
Aminosalicylic Acid
The therapeutic efficacy of Imidapril can be decreased when used in combination with Aminosalicylic Acid.
Amiodarone
The risk or severity of adverse effects can be increased when Amiodarone is combined with Imidapril.
Amitriptyline
The serum concentration of Amitriptyline can be increased when it is combined with Imidapril.
Amlodipine
Amlodipine may increase the hypotensive activities of Imidapril.
Amobarbital
Amobarbital may increase the hypotensive activities of Imidapril.
Amoxapine
The serum concentration of Amoxapine can be increased when it is combined with Imidapril.
Amphetamine
Amphetamine may increase the hypotensive activities of Imidapril.
Amphotericin B
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Imidapril.
amphotericin B liposomal
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Imidapril.
Amyl Nitrite
The risk or severity of adverse effects can be increased when Imidapril is combined with Amyl Nitrite.
Anhydrous Tacrolimus
The metabolism of Tacrolimus can be decreased when combined with Imidapril.
Antipyrine
The risk or severity of adverse effects can be increased when Antipyrine is combined with Imidapril.
Apazone
The risk or severity of adverse effects can be increased when Azapropazone is combined with Imidapril.
Apomorphine
The risk or severity of adverse effects can be increased when Apomorphine is combined with Imidapril.
Apraclonidine
The risk or severity of adverse effects can be increased when Imidapril is combined with Apraclonidine.
Apremilast
The risk or severity of adverse effects can be increased when Apremilast is combined with Imidapril.
Aprotinin
Aprotinin may decrease the antihypertensive activities of Imidapril.
Aripiprazole
Aripiprazole may increase the hypotensive activities of Imidapril.
Arsenic Trioxide
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Imidapril.
Aspirin
The therapeutic efficacy of Imidapril can be decreased when used in combination with Acetylsalicylic acid.
Atenolol
Atenolol may increase the hypotensive activities of Imidapril.
Atorvastatin
The risk or severity of adverse effects can be increased when Atorvastatin is combined with Imidapril.
Avanafil
Avanafil may increase the antihypertensive activities of Imidapril.
Azathioprine
The risk or severity of anemia and severe leukopenia can be increased when Imidapril is combined with Azathioprine.
Azelastine
The risk or severity of adverse effects can be increased when Azelastine is combined with Imidapril.
Azilsartan
The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Imidapril.
Azilsartan kamedoxomil
The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Imidapril.
Azilsartan Medoxomil
The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Imidapril.
Azosemide
Azosemide may increase the hypotensive activities of Imidapril.
Balsalazide
The risk or severity of adverse effects can be increased when Balsalazide is combined with Imidapril.
Barbexaclone
Barbexaclone may increase the hypotensive activities of Imidapril.
Barbital
Barbital may increase the hypotensive activities of Imidapril.
Benazepril
Benazepril may increase the hypotensive activities of Imidapril.
Bendroflumethiazide
The risk or severity of hypotension can be increased when Bendroflumethiazide is combined with Imidapril.
Benzydamine
The risk or severity of adverse effects can be increased when Benzydamine is combined with Imidapril.
Bepridil
The risk or severity of adverse effects can be increased when Bepridil is combined with Imidapril.
Betaxolol
Betaxolol may increase the hypotensive activities of Imidapril.
Bethanidine
Bethanidine may increase the hypotensive activities of Imidapril.
Bimatoprost
Bimatoprost may increase the hypotensive activities of Imidapril.
Bisoprolol
Bisoprolol may increase the hypotensive activities of Imidapril.
Boceprevir
The serum concentration of Imidapril can be decreased when it is combined with Boceprevir.
Bortezomib
The risk or severity of adverse effects can be increased when Bortezomib is combined with Imidapril.
Bosentan
Bosentan may increase the hypotensive activities of Imidapril.
Bretylium
Bretylium may increase the hypotensive activities of Imidapril.
Brimonidine
Brimonidine may increase the antihypertensive activities of Imidapril.
Bromfenac
The risk or severity of adverse effects can be increased when Bromfenac is combined with Imidapril.
Bromocriptine
The serum concentration of Bromocriptine can be increased when it is combined with Imidapril.
Bufexamac
The risk or severity of adverse effects can be increased when Bufexamac is combined with Imidapril.
Bumetanide
Bumetanide may increase the hypotensive activities of Imidapril.
Bupivacaine
The risk or severity of adverse effects can be increased when Bupivacaine is combined with Imidapril.
Bupranolol
Bupranolol may increase the hypotensive activities of Imidapril.
Cabergoline
The serum concentration of Cabergoline can be increased when it is combined with Imidapril.
Cafedrine
Imidapril may increase the hypotensive activities of Cafedrine.
Canagliflozin
The risk or severity of renal failure and hyperkalemia can be increased when Canagliflozin is combined with Imidapril.
Canagliflozin Anhydrous
The risk or severity of renal failure and hyperkalemia can be increased when Canagliflozin is combined with Imidapril.
Candesartan
The risk or severity of adverse effects can be increased when Candesartan is combined with Imidapril.
Candesartan Cilexetil
The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Imidapril.
Captopril
Captopril may increase the hypotensive activities of Imidapril.
Carbamazepine
The metabolism of Imidapril can be increased when combined with Carbamazepine.
Carprofen
The risk or severity of adverse effects can be increased when Carprofen is combined with Imidapril.
Carteolol
Carteolol may increase the hypotensive activities of Imidapril.
Carvedilol
Carvedilol may increase the hypotensive activities of Imidapril.
Celecoxib
The risk or severity of adverse effects can be increased when Celecoxib is combined with Imidapril.
Celiprolol
Celiprolol may increase the hypotensive activities of Imidapril.
Chloroquine
The risk or severity of adverse effects can be increased when Chloroquine is combined with Imidapril.
Chlorothiazide
The risk or severity of hypotension can be increased when Chlorothiazide is combined with Imidapril.
Chlorotrianisene
The serum concentration of Chlorotrianisene can be decreased when it is combined with Imidapril.
Chlorpromazine
The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Imidapril.
Chlorthalidone
The risk or severity of hypotension can be increased when Chlorthalidone is combined with Imidapril.
Choline Magnesium Trisalicyclate
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Imidapril.
Cicletanine
Imidapril may increase the hypotensive activities of Cicletanine.
Cilazapril
Cilazapril may increase the hypotensive activities of Imidapril.
Ciprofloxacin
The risk or severity of ventricular arrhythmias can be increased when Imidapril is combined with Ciprofloxacin.
Clarithromycin
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Imidapril.
Clevidipine
The risk or severity of adverse effects can be increased when Imidapril is combined with Clevidipine.
Clevidipine butyrate
The risk or severity of adverse effects can be increased when Imidapril is combined with Clevidipine.
Clofarabine
The risk or severity of adverse effects can be increased when Clofarabine is combined with Imidapril.
Clomipramine
The serum concentration of Clomipramine can be increased when it is combined with Imidapril.
Clonidine
Clonidine may increase the hypotensive activities of Imidapril.
Clonixin
The risk or severity of adverse effects can be increased when Clonixin is combined with Imidapril.
Clozapine
The risk or severity of adverse effects can be increased when Clozapine is combined with Imidapril.
Conivaptan
The risk or severity of adverse effects can be increased when Conivaptan is combined with Imidapril.
Cryptenamine
Cryptenamine may increase the hypotensive activities of Imidapril.
Curcumin
The risk or severity of adverse effects can be increased when Curcumin is combined with Imidapril.
Cyclobenzaprine
The serum concentration of Cyclobenzaprine can be increased when it is combined with Imidapril.
Cyclopenthiazide
The risk or severity of hypotension can be increased when Cyclopenthiazide is combined with Imidapril.
Cyclophosphamide
The risk or severity of adverse effects can be increased when Imidapril is combined with Cyclophosphamide.
Cyclophosphamide Anhydrous
The risk or severity of adverse effects can be increased when Imidapril is combined with Cyclophosphamide.
Cyclosporine
The serum concentration of Cyclosporine can be increased when it is combined with Imidapril.
Cyclothiazide
Cyclothiazide may increase the hypotensive activities of Imidapril.
Dapagliflozin
The risk or severity of adverse effects can be increased when Imidapril is combined with Dapagliflozin.
Debrisoquin
Debrisoquin may increase the hypotensive activities of Imidapril.
Delavirdine
The serum concentration of Delavirdine can be decreased when it is combined with Imidapril.
Deserpidine
Imidapril may increase the hypotensive activities of Deserpidine.
Desflurane
The risk or severity of adverse effects can be increased when Desflurane is combined with Imidapril.
Desipramine
The serum concentration of Desipramine can be increased when it is combined with Imidapril.
Dexmedetomidine
The risk or severity of adverse effects can be increased when Imidapril is combined with Dexmedetomidine.
Diazoxide
Diazoxide may increase the hypotensive activities of Imidapril.
Dichlorphenamide
The risk or severity of adverse effects can be increased when Imidapril is combined with Diclofenamide.
Diclofenac
The risk or severity of adverse effects can be increased when Diclofenac is combined with Imidapril.
Dienestrol
The serum concentration of Dienestrol can be decreased when it is combined with Imidapril.
Diethylstilbestrol
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Imidapril.
Diflunisal
The therapeutic efficacy of Imidapril can be decreased when used in combination with Diflunisal.
Digoxin
The serum concentration of Digoxin can be increased when it is combined with Imidapril.
Dihydralazine
Dihydralazine may increase the hypotensive activities of Imidapril.
Dihydroergotamine
The serum concentration of Dihydroergotamine can be increased when it is combined with Imidapril.
Diltiazem
The metabolism of Diltiazem can be decreased when combined with Imidapril.
Dinutuximab
The risk or severity of adverse effects can be increased when Imidapril is combined with Dinutuximab.
Dipyridamole
The risk or severity of adverse effects can be increased when Imidapril is combined with Dipyridamole.
Dipyrone
The risk or severity of adverse effects can be increased when Metamizole is combined with Imidapril.
Dorzolamide
Dorzolamide may increase the hypotensive activities of Imidapril.
Dothiepin
The serum concentration of Dosulepin can be increased when it is combined with Imidapril.
Doxazosin
Doxazosin may increase the hypotensive activities of Imidapril.
Doxepin
The serum concentration of Doxepin can be increased when it is combined with Imidapril.
Drospirenone
Imidapril may increase the hyperkalemic activities of Drospirenone.
Droxicam
The risk or severity of adverse effects can be increased when Droxicam is combined with Imidapril.
Duloxetine
Imidapril may increase the orthostatic hypotensive activities of Duloxetine.
Dyphylline
The serum concentration of Dyphylline can be decreased when it is combined with Imidapril.
Empagliflozin
The risk or severity of adverse effects can be increased when Imidapril is combined with Empagliflozin.
Enalapril
Enalapril may increase the hypotensive activities of Imidapril.
Enalaprilat
The risk or severity of adverse effects can be increased when Enalaprilat is combined with Imidapril.
Enalaprilat Anhydrous
The risk or severity of adverse effects can be increased when Enalaprilat is combined with Imidapril.
Enfuvirtide
The serum concentration of Enfuvirtide can be increased when it is combined with Imidapril.
Eplerenone
Eplerenone may increase the hyperkalemic activities of Imidapril.
Epoprostenol
The risk or severity of adverse effects can be increased when Epoprostenol is combined with Imidapril.
Eprosartan
The risk or severity of adverse effects can be increased when Eprosartan is combined with Imidapril.
ergoloid mesylates, USP
The serum concentration of Ergoloid mesylate can be increased when it is combined with Imidapril.
Ergonovine
The serum concentration of Ergonovine can be increased when it is combined with Imidapril.
Ergotamine
The serum concentration of Ergotamine can be increased when it is combined with Imidapril.
Esmolol
The risk or severity of adverse effects can be increased when Imidapril is combined with Esmolol.
Estradiol
The serum concentration of Estradiol can be decreased when it is combined with Imidapril.
Estramustine
The serum concentration of Estramustine can be decreased when it is combined with Imidapril.
Estrogens, Conjugated (USP)
The serum concentration of Conjugated estrogens can be decreased when it is combined with Imidapril.
Estrogens, Esterified (USP)
The serum concentration of Estrogens, esterified can be decreased when it is combined with Imidapril.
Etanercept
The risk or severity of adverse effects can be increased when Etanercept is combined with Imidapril.
Ethacrynate
Etacrynic acid may increase the hypotensive activities of Imidapril.
Ethacrynic Acid
Etacrynic acid may increase the hypotensive activities of Imidapril.
Ethinyl Estradiol
The serum concentration of Ethinyl Estradiol can be decreased when it is combined with Imidapril.
Etodolac
The risk or severity of adverse effects can be increased when Etodolac is combined with Imidapril.
Etofenamate
The risk or severity of adverse effects can be increased when Etofenamate is combined with Imidapril.
Etoricoxib
The risk or severity of adverse effects can be increased when Etoricoxib is combined with Imidapril.
Etravirine
The serum concentration of Etravirine can be decreased when it is combined with Imidapril.
Evening primrose oil
The risk or severity of adverse effects can be increased when Evening primrose oil is combined with Imidapril.
Everolimus
The risk or severity of adverse effects can be increased when Everolimus is combined with Imidapril.
Felbinac
The risk or severity of adverse effects can be increased when Felbinac is combined with Imidapril.
Felodipine
Felodipine may increase the hypotensive activities of Imidapril.
Fenbufen
The risk or severity of adverse effects can be increased when Fenbufen is combined with Imidapril.
Fenoldopam
The risk or severity of adverse effects can be increased when Fenoldopam is combined with Imidapril.
Fenoprofen
The risk or severity of adverse effects can be increased when Fenoprofen is combined with Imidapril.
Ferulic Acid
Ferulic acid may increase the hypotensive activities of Imidapril.
Fibrinolysis Inhibitor
Aprotinin may decrease the antihypertensive activities of Imidapril.
Floctafenine
The risk or severity of adverse effects can be increased when Floctafenine is combined with Imidapril.
Flurbiprofen
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Imidapril.
Fosinopril
Fosinopril may increase the hypotensive activities of Imidapril.
Furazolidone
Furazolidone may increase the hypotensive activities of Imidapril.
Furosemide
Furosemide may increase the hypotensive activities of Imidapril.
Garlic Allergenic Extract
The serum concentration of Imidapril can be decreased when it is combined with Garlic.
Gold Sodium Thiomalate
The risk or severity of hypotension, nitritoid reactions, facial flushing, nausea, and vomiting can be increased when Imidapril is combined with Sodium aurothiomalate.
Guanabenz
Guanabenz may increase the hypotensive activities of Imidapril.
Guanadrel
Guanadrel may increase the hypotensive activities of Imidapril.
Guanethidine
Guanethidine may increase the hypotensive activities of Imidapril.
Guanfacine
Guanfacine may increase the hypotensive activities of Imidapril.
Halothane
The risk or severity of adverse effects can be increased when Halothane is combined with Imidapril.
Heparin
The risk or severity of hyperkalemia can be increased when Imidapril is combined with Heparin.
Hexobarbital
Hexobarbital may increase the hypotensive activities of Imidapril.
Hydralazine
Hydralazine may increase the hypotensive activities of Imidapril.
Hydrochlorothiazide
The risk or severity of hypotension can be increased when Hydrochlorothiazide is combined with Imidapril.
Hydroflumethiazide
The risk or severity of hypotension can be increased when Hydroflumethiazide is combined with Imidapril.
Hypoxis hemerocallidea root extract
The metabolism of Imidapril can be increased when combined with St. John's Wort.
Ibuprofen
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Imidapril.
Icatibant
Icatibant may decrease the antihypertensive activities of Imidapril.
Iloprost
The risk or severity of adverse effects can be increased when Iloprost is combined with Imidapril.
Imipramine
The serum concentration of Imipramine can be increased when it is combined with Imidapril.
Indapamide
The risk or severity of hypotension can be increased when Indapamide is combined with Imidapril.
Indobufen
The risk or severity of adverse effects can be increased when Indobufen is combined with Imidapril.
Indomethacin
The risk or severity of adverse effects can be increased when Indomethacin is combined with Imidapril.
Indoramin
The risk or severity of adverse effects can be increased when Imidapril is combined with Indoramin.
Iproniazid
Iproniazid may increase the hypotensive activities of Imidapril.
Irbesartan
The risk or severity of adverse effects can be increased when Irbesartan is combined with Imidapril.
Iron
Iron can cause a decrease in the absorption of Imidapril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Iron Carbonyl
Iron can cause a decrease in the absorption of Imidapril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Iron-Dextran Complex
The risk or severity of adverse effects can be increased when Imidapril is combined with Iron Dextran.
Isocarboxazid
The risk or severity of adverse effects can be increased when Imidapril is combined with Isocarboxazid.
Isoflurane
The risk or severity of adverse effects can be increased when Imidapril is combined with Isoflurane.
Isosorbide Dinitrate
The risk or severity of adverse effects can be increased when Imidapril is combined with Isosorbide Dinitrate.
Isosorbide Mononitrate
The risk or severity of adverse effects can be increased when Imidapril is combined with Isosorbide Mononitrate.
Isoxsuprine
The risk or severity of adverse effects can be increased when Imidapril is combined with Isoxsuprine.
Isradipine
Isradipine may increase the hypotensive activities of Imidapril.
Kebuzone
The risk or severity of adverse effects can be increased when Kebuzone is combined with Imidapril.
Ketanserin
Ketanserin may increase the hypotensive activities of Imidapril.
Ketoprofen
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Imidapril.
Ketorolac
The risk or severity of adverse effects can be increased when Ketorolac is combined with Imidapril.
Labetalol
Labetalol may increase the hypotensive activities of Imidapril.
Lacidipine
Imidapril may increase the hypotensive activities of Lacidipine.
Lanthanum Carbonate
The serum concentration of Imidapril can be decreased when it is combined with Lanthanum carbonate.
Latanoprost
Latanoprost may increase the hypotensive activities of Imidapril.
Leflunomide
The risk or severity of adverse effects can be increased when Leflunomide is combined with Imidapril.
Lercanidipine
The risk or severity of adverse effects can be increased when Imidapril is combined with Lercanidipine.
Levobunolol
The risk or severity of adverse effects can be increased when Imidapril is combined with Levobunolol.
Levobupivacaine
The risk or severity of adverse effects can be increased when Imidapril is combined with Levobupivacaine.
Levodopa
Imidapril may increase the orthostatic hypotensive activities of Levodopa.
Levosimendan
The risk or severity of adverse effects can be increased when Imidapril is combined with Levosimendan.
Limonene, (+)-
The risk or severity of adverse effects can be increased when (4R)-limonene is combined with Imidapril.
Linagliptin
The risk or severity of adverse effects can be increased when Linagliptin is combined with Imidapril.
Lisinopril
Lisinopril may increase the hypotensive activities of Imidapril.
Lisinopril Anhydrous
Lisinopril may increase the hypotensive activities of Imidapril.
Lithium
The serum concentration of Lithium can be increased when it is combined with Imidapril.
Lithium Cation
The serum concentration of Lithium can be increased when it is combined with Imidapril.
Lofexidine
The risk or severity of adverse effects can be increased when Imidapril is combined with Lofexidine.
Lornoxicam
The risk or severity of adverse effects can be increased when Lornoxicam is combined with Imidapril.
Losartan
The risk or severity of adverse effects can be increased when Losartan is combined with Imidapril.
Lovastatin
The serum concentration of Lovastatin can be increased when it is combined with Imidapril.
Loxoprofen
The risk or severity of adverse effects can be increased when Loxoprofen is combined with Imidapril.
Macitentan
Imidapril may increase the hypotensive activities of Macitentan.
Magnesium Salicylate
The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Imidapril.
Manidipine
Manidipine may increase the hypotensive activities of Imidapril.
Mannitol
The risk or severity of adverse effects can be increased when Imidapril is combined with Mannitol.
Masoprocol
The risk or severity of adverse effects can be increased when Masoprocol is combined with Imidapril.
Mecamylamine
Mecamylamine may increase the hypotensive activities of Imidapril.
Meclofenamate
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Imidapril.
Meclofenamic Acid
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Imidapril.
Mefenamic Acid
The risk or severity of adverse effects can be increased when Mefenamic acid is combined with Imidapril.
Meloxicam
The risk or severity of adverse effects can be increased when Meloxicam is combined with Imidapril.
Meperidine
The risk or severity of adverse effects can be increased when Imidapril is combined with Pethidine.
Mephobarbital
Methylphenobarbital may increase the hypotensive activities of Imidapril.
Mepirodipine
Imidapril may increase the antihypertensive activities of Barnidipine.
Mesalamine
The therapeutic efficacy of Imidapril can be decreased when used in combination with Mesalazine.
Mestranol
The serum concentration of Mestranol can be decreased when it is combined with Imidapril.
Methazolamide
The risk or severity of adverse effects can be increased when Imidapril is combined with Methazolamide.
Methohexital
Methohexital may increase the hypotensive activities of Imidapril.
Methyclothiazide
The risk or severity of hypotension can be increased when Methyclothiazide is combined with Imidapril.
Methyl Salicylate
The therapeutic efficacy of Imidapril can be decreased when used in combination with Methyl salicylate.
Methyldopa
Methyldopa may increase the hypotensive activities of Imidapril.
METHYLDOPA ANHYDROUS
Methyldopa may increase the hypotensive activities of Imidapril.
Methylene blue
Methylene blue may increase the hypotensive activities of Imidapril.
Methylergonovine
The serum concentration of Methylergometrine can be increased when it is combined with Imidapril.
Methylphenidate
Methylphenidate may decrease the antihypertensive activities of Imidapril.
Metipranolol
Metipranolol may increase the hypotensive activities of Imidapril.
Metolazone
The risk or severity of hypotension can be increased when Metolazone is combined with Imidapril.
Metoprolol
Metoprolol may increase the hypotensive activities of Imidapril.
Metyrosine
Imidapril may increase the hypotensive activities of Metyrosine.
Mibefradil
Mibefradil may increase the hypotensive activities of Imidapril.
Midazolam
The serum concentration of Midazolam can be increased when it is combined with Imidapril.
Minaprine
Minaprine may increase the hypotensive activities of Imidapril.
Minoxidil
Minoxidil may increase the hypotensive activities of Imidapril.
Mirtazapine
The serum concentration of Mirtazapine can be increased when it is combined with Imidapril.
Moclobemide
Moclobemide may increase the hypotensive activities of Imidapril.
Moexipril
Moexipril may increase the hypotensive activities of Imidapril.
Molsidomine
Molsidomine may increase the hypotensive activities of Imidapril.
Morphine
The risk or severity of adverse effects can be increased when Imidapril is combined with Morphine.
Moxonidine
The risk or severity of adverse effects can be increased when Imidapril is combined with Moxonidine.
MYCOPHENOLATE
The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Imidapril.
Mycophenolate Mofetil
The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Imidapril.
Mycophenolic Acid
The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Imidapril.
Nabilone
The risk or severity of adverse effects can be increased when Imidapril is combined with Nabilone.
Nabumetone
The risk or severity of adverse effects can be increased when Nabumetone is combined with Imidapril.
Nadolol
Nadolol may increase the hypotensive activities of Imidapril.
Naftifine
The risk or severity of adverse effects can be increased when Naftifine is combined with Imidapril.
Naproxen
The risk or severity of adverse effects can be increased when Naproxen is combined with Imidapril.
Nebivolol
Nebivolol may increase the hypotensive activities of Imidapril.
Nefazodone
The serum concentration of Nefazodone can be increased when it is combined with Imidapril.
Nepafenac
The risk or severity of adverse effects can be increased when Nepafenac is combined with Imidapril.
Nesiritide
The risk or severity of adverse effects can be increased when Imidapril is combined with Nesiritide.
Nialamide
Nialamide may increase the hypotensive activities of Imidapril.
Nicardipine
Nicardipine may increase the hypotensive activities of Imidapril.
Nicorandil
Nicorandil may increase the hypotensive activities of Imidapril.
Nifedipine
The risk or severity of adverse effects can be increased when Imidapril is combined with Nifedipine.
Niflumic Acid
The risk or severity of adverse effects can be increased when Niflumic Acid is combined with Imidapril.
Nilvadipine
The risk or severity of adverse effects can be increased when Imidapril is combined with Nilvadipine.
Nimesulide
The risk or severity of adverse effects can be increased when Nimesulide is combined with Imidapril.
Nimodipine
Nimodipine may increase the hypotensive activities of Imidapril.
Nisoldipine
Nisoldipine may increase the hypotensive activities of Imidapril.
Nitrendipine
The risk or severity of adverse effects can be increased when Imidapril is combined with Nitrendipine.
Nitric Oxide
The risk or severity of adverse effects can be increased when Imidapril is combined with Nitric Oxide.
Nitroglycerin
The risk or severity of adverse effects can be increased when Imidapril is combined with Nitroglycerin.
Nitroprusside
Nitroprusside may increase the hypotensive activities of Imidapril.
Nortriptyline
The serum concentration of Nortriptyline can be increased when it is combined with Imidapril.
Obinutuzumab
Imidapril may increase the hypotensive activities of Obinutuzumab.
Oenothera biennis seed extract
The risk or severity of adverse effects can be increased when Evening primrose oil is combined with Imidapril.
Olmesartan
The risk or severity of adverse effects can be increased when Olmesartan is combined with Imidapril.
Olopatadine
The risk or severity of adverse effects can be increased when Olopatadine is combined with Imidapril.
Olsalazine
The risk or severity of adverse effects can be increased when Olsalazine is combined with Imidapril.
Opipramol
The serum concentration of Opipramol can be increased when it is combined with Imidapril.
Oxaprozin
The risk or severity of adverse effects can be increased when Oxaprozin is combined with Imidapril.
Oxprenolol
The risk or severity of adverse effects can be increased when Imidapril is combined with Oxprenolol.
Oxyphenbutazone
The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Imidapril.
Paclitaxel
The risk or severity of adverse effects can be increased when Imidapril is combined with Paclitaxel.
Papaverine
The risk or severity of adverse effects can be increased when Imidapril is combined with Papaverine.
Parecoxib
The risk or severity of adverse effects can be increased when Parecoxib is combined with Imidapril.
Paregoric
The risk or severity of adverse effects can be increased when Imidapril is combined with Morphine.
Pargyline
Pargyline may increase the hypotensive activities of Imidapril.
Parthenolide
The risk or severity of adverse effects can be increased when Parthenolide is combined with Imidapril.
Penbutolol
Penbutolol may increase the hypotensive activities of Imidapril.
Pentobarbital
Pentobarbital may increase the hypotensive activities of Imidapril.
Pentoxifylline
Pentoxifylline may increase the hypotensive activities of Imidapril.
Perindopril
Perindopril may increase the hypotensive activities of Imidapril.
Phenelzine
The risk or severity of adverse effects can be increased when Imidapril is combined with Phenelzine.
Phenobarbital
Phenobarbital may increase the hypotensive activities of Imidapril.
Phenoxybenzamine
The risk or severity of adverse effects can be increased when Imidapril is combined with Phenoxybenzamine.
Phentolamine
The risk or severity of adverse effects can be increased when Imidapril is combined with Phentolamine.
Phentolamine Mesylate
The risk or severity of adverse effects can be increased when Imidapril is combined with Phentolamine.
Phenylbutazone
The risk or severity of adverse effects can be increased when Phenylbutazone is combined with Imidapril.
Pimecrolimus
The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Imidapril.
Pinacidil
Pinacidil may increase the hypotensive activities of Imidapril.
Pindolol
Pindolol may increase the hypotensive activities of Imidapril.
Pipamperone
The risk or severity of adverse effects can be increased when Imidapril is combined with Pipamperone.
Piretanide
Piretanide may increase the hypotensive activities of Imidapril.
Pirfenidone
The risk or severity of adverse effects can be increased when Pirfenidone is combined with Imidapril.
Piroxicam
The risk or severity of adverse effects can be increased when Piroxicam is combined with Imidapril.
Piroxicam-Beta-Cyclodextrin
The risk or severity of adverse effects can be increased when Piroxicam is combined with Imidapril.
Polythiazide
The risk or severity of hypotension can be increased when Polythiazide is combined with Imidapril.
Potassium
Potassium may increase the hyperkalemic activities of Imidapril.
Potassium Bicarbonate
Potassium bicarbonate may increase the hyperkalemic activities of Imidapril.
Potassium Chloride
Potassium Chloride may increase the hyperkalemic activities of Imidapril.
Potassium Citrate
Potassium Citrate may increase the hyperkalemic activities of Imidapril.
Pramipexole
The risk or severity of adverse effects can be increased when Imidapril is combined with Pramipexole.
Prazosin
Prazosin may increase the hypotensive activities of Imidapril.
Pregabalin
The risk or severity of angioedema can be increased when Imidapril is combined with Pregabalin.
Primidone
Primidone may increase the hypotensive activities of Imidapril.
Procarbazine
Procarbazine may increase the hypotensive activities of Imidapril.
Propofol
The risk or severity of adverse effects can be increased when Imidapril is combined with Propofol.
Propranolol
Propranolol may increase the hypotensive activities of Imidapril.
Protriptyline
The serum concentration of Protriptyline can be increased when it is combined with Imidapril.
Quetiapine
The risk or severity of adverse effects can be increased when Imidapril is combined with Quetiapine.
Quetiapine fumarate
The risk or severity of adverse effects can be increased when Imidapril is combined with Quetiapine.
Quinapril
Quinapril may increase the hypotensive activities of Imidapril.
Quinethazone
The risk or severity of hypotension can be increased when Quinethazone is combined with Imidapril.
Quinine
Quinine may increase the hypotensive activities of Imidapril.
Ramipril
Ramipril may increase the hypotensive activities of Imidapril.
Rasagiline
The risk or severity of adverse effects can be increased when Imidapril is combined with Rasagiline.
Remifentanil
The risk or severity of adverse effects can be increased when Imidapril is combined with Remifentanil.
Rescinnamine
Imidapril may increase the hypotensive activities of Rescinnamine.
Reserpine
Reserpine may increase the hypotensive activities of Imidapril.
Resveratrol
The risk or severity of adverse effects can be increased when Resveratrol is combined with Imidapril.
Rilmenidine
Rilmenidine may increase the hypotensive activities of Imidapril.
Riociguat
The serum concentration of Riociguat can be increased when it is combined with Imidapril.
Risperidone
Imidapril may increase the hypotensive activities of Risperidone.
Rituximab
Imidapril may increase the hypotensive activities of Rituximab.
Rofecoxib
The risk or severity of adverse effects can be increased when Rofecoxib is combined with Imidapril.
Ropinirole
The risk or severity of adverse effects can be increased when Imidapril is combined with Ropinirole.
Ropivacaine
The risk or severity of adverse effects can be increased when Imidapril is combined with Ropivacaine.
Rotigotine
The risk or severity of adverse effects can be increased when Imidapril is combined with Rotigotine.
Sacubitril
The risk or severity of angioedema can be increased when Imidapril is combined with Sacubitril.
Salicylamide
The risk or severity of adverse effects can be increased when Salicylamide is combined with Imidapril.
Salicylic Acid
The therapeutic efficacy of Imidapril can be decreased when used in combination with Salicylic acid.
Salsalate
The risk or severity of adverse effects can be increased when Salsalate is combined with Imidapril.
Saralasin
The risk or severity of adverse effects can be increased when Saralasin is combined with Imidapril.
Saxagliptin
The risk or severity of adverse effects can be increased when Saxagliptin is combined with Imidapril.
Saxagliptin Anhydrous
The risk or severity of adverse effects can be increased when Saxagliptin is combined with Imidapril.
Secobarbital
Secobarbital may increase the hypotensive activities of Imidapril.
Selegiline
The risk or severity of adverse effects can be increased when Imidapril is combined with Selegiline.
Selexipag
Selexipag may increase the hypotensive activities of Imidapril.
Serratiopeptidase
The risk or severity of adverse effects can be increased when Serrapeptase is combined with Imidapril.
Sevoflurane
The risk or severity of adverse effects can be increased when Imidapril is combined with Sevoflurane.
Sildenafil
The serum concentration of Sildenafil can be increased when it is combined with Imidapril.
Simvastatin
The serum concentration of Simvastatin can be increased when it is combined with Imidapril.
Sirolimus
The risk or severity of angioedema can be increased when Sirolimus is combined with Imidapril.
Sitagliptin
The risk or severity of adverse effects can be increased when Sitagliptin is combined with Imidapril.
Sitagliptin Phosphate
The risk or severity of adverse effects can be increased when Sitagliptin is combined with Imidapril.
Sodium Phosphate
Imidapril may increase the nephrotoxic activities of Sodium phosphate.
Sodium Phosphate, Monobasic
Imidapril may increase the nephrotoxic activities of Sodium phosphate.
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
Imidapril may increase the nephrotoxic activities of Sodium phosphate.
Sotalol
The risk or severity of adverse effects can be increased when Imidapril is combined with Sotalol.
Spirapril
Spirapril may increase the hypotensive activities of Imidapril.
Spironolactone
The risk or severity of adverse effects can be increased when Imidapril is combined with Spironolactone.
ST. JOHN'S WORT EXTRACT
The metabolism of Imidapril can be increased when combined with St. John's Wort.
Streptokinase
The risk or severity of adverse effects can be increased when Imidapril is combined with Streptokinase.
Sufentanil
The risk or severity of adverse effects can be increased when Imidapril is combined with Sufentanil.
Sulfasalazine
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Imidapril.
Sulindac
The risk or severity of adverse effects can be increased when Sulindac is combined with Imidapril.
Suprofen
The risk or severity of adverse effects can be increased when Suprofen is combined with Imidapril.
synthetic conjugated estrogens, A
The serum concentration of Synthetic Conjugated Estrogens, A can be decreased when it is combined with Imidapril.
Tacrolimus
The metabolism of Tacrolimus can be decreased when combined with Imidapril.
Tadalafil
Tadalafil may increase the antihypertensive activities of Imidapril.
Talinolol
Talinolol may increase the hypotensive activities of Imidapril.
Tamsulosin
The risk or severity of adverse effects can be increased when Imidapril is combined with Tamsulosin.
Telmisartan
The risk or severity of adverse effects can be increased when Telmisartan is combined with Imidapril.
Temsirolimus
The risk or severity of adverse effects can be increased when Imidapril is combined with Temsirolimus.
Tenoxicam
The risk or severity of adverse effects can be increased when Tenoxicam is combined with Imidapril.
Terazosin
The risk or severity of adverse effects can be increased when Imidapril is combined with Terazosin.
Teriflunomide
The risk or severity of adverse effects can be increased when Teriflunomide is combined with Imidapril.
Terlipressin
Terlipressin may increase the hypotensive activities of Imidapril.
Thalidomide
The risk or severity of adverse effects can be increased when Imidapril is combined with Thalidomide.
Theodrenaline
Imidapril may increase the hypotensive activities of Theodrenaline.
Theophylline
The serum concentration of Theophylline can be decreased when it is combined with Imidapril.
Theophylline anhydrous
The serum concentration of Theophylline can be decreased when it is combined with Imidapril.
Thiamylal
Thiamylal may increase the hypotensive activities of Imidapril.
Thiopental
Thiopental may increase the hypotensive activities of Imidapril.
Thiopental Sodium
Thiopental may increase the hypotensive activities of Imidapril.
Thioridazine
The risk or severity of adverse effects can be increased when Imidapril is combined with Thioridazine.
Tianeptine
The serum concentration of Tianeptine can be increased when it is combined with Imidapril.
Tiaprofenic Acid
The risk or severity of adverse effects can be increased when Tiaprofenic acid is combined with Imidapril.
Tibolone
Tibolone may increase the hypotensive activities of Imidapril.
Timolol
Timolol may increase the hypotensive activities of Imidapril.
Timolol Anhydrous
Timolol may increase the hypotensive activities of Imidapril.
Tipranavir
The serum concentration of Imidapril can be decreased when it is combined with Tipranavir.
Tizanidine
The risk or severity of hypotension can be increased when Tizanidine is combined with Imidapril.
Tolazoline
The risk or severity of adverse effects can be increased when Imidapril is combined with Tolazoline.
Tolcapone
The risk or severity of adverse effects can be increased when Imidapril is combined with Tolcapone.
Tolfenamic Acid
The risk or severity of adverse effects can be increased when Tolfenamic Acid is combined with Imidapril.
Tolmetin
The risk or severity of adverse effects can be increased when Tolmetin is combined with Imidapril.
Toloxatone
Toloxatone may increase the hypotensive activities of Imidapril.
Tolvaptan
Tolvaptan may increase the hyperkalemic activities of Imidapril.
Torsemide
Torasemide may increase the hypotensive activities of Imidapril.
Trandolapril
Trandolapril may increase the hypotensive activities of Imidapril.
Tranilast
The risk or severity of adverse effects can be increased when Tranilast is combined with Imidapril.
Tranylcypromine
The risk or severity of adverse effects can be increased when Imidapril is combined with Tranylcypromine.
Travoprost
Travoprost may increase the hypotensive activities of Imidapril.
Treprostinil
Treprostinil may increase the hypotensive activities of Imidapril.
Tretinoin
The risk or severity of adverse effects can be increased when Imidapril is combined with Tretinoin.
Triamterene
Triamterene may increase the hyperkalemic activities of Imidapril.
Triazolam
The serum concentration of Triazolam can be increased when it is combined with Imidapril.
Trichlormethiazide
The risk or severity of hypotension can be increased when Trichlormethiazide is combined with Imidapril.
Trimethaphan
Trimethaphan may increase the hypotensive activities of Imidapril.
Trimethoprim
Trimethoprim may increase the hyperkalemic activities of Imidapril.
Trimipramine
The serum concentration of Trimipramine can be increased when it is combined with Imidapril.
Trolamine Salicylate
The therapeutic efficacy of Imidapril can be decreased when used in combination with Trolamine salicylate.
UNOPROSTONE
Unoprostone may increase the hypotensive activities of Imidapril.
Urapidil
Urapidil may increase the hypotensive activities of Imidapril.
Valdecoxib
The risk or severity of adverse effects can be increased when Valdecoxib is combined with Imidapril.
Valproate
The serum concentration of Valproic Acid can be decreased when it is combined with Imidapril.
Valproic Acid
The serum concentration of Valproic Acid can be decreased when it is combined with Imidapril.
Valsartan
The risk or severity of adverse effects can be increased when Valsartan is combined with Imidapril.
Vardenafil
Vardenafil may increase the antihypertensive activities of Imidapril.
Verapamil
The metabolism of Verapamil can be decreased when combined with Imidapril.
Vildagliptin
The risk or severity of adverse effects can be increased when Vildagliptin is combined with Imidapril.
Vincamine
Imidapril may increase the hypotensive activities of Vincamine.
Vinpocetine
Imidapril may increase the hypotensive activities of Vinpocetine.
Xylometazoline
Xylometazoline may increase the hypotensive activities of Imidapril.
Yohimbine
Yohimbine may decrease the antihypertensive activities of Imidapril.
Zidovudine
The serum concentration of Zidovudine can be decreased when it is combined with Imidapril.
Zileuton
The risk or severity of adverse effects can be increased when Zileuton is combined with Imidapril.
Zofenopril
Imidapril may increase the hypotensive activities of Zofenopril.
Zomepirac
The risk or severity of adverse effects can be increased when Zomepirac is combined with Imidapril.
